LIPOPOLYSACCHARIDE INHIBITS ACTIVATION OF LATENT TRANSFORMING GROWTH-FACTOR-BETA IN BOVINE ENDOTHELIAL-CELLS

被引:15
作者
KOJIMA, S
VERNOOY, R
MOSCATELLI, D
AMANUMA, H
RIFKIN, DB
机构
[1] NYU, SCH MED, DEPT CELL BIOL, NEW YORK, NY 10016 USA
[2] NYU, SCH MED, KAPLAN CANC CTR, NEW YORK, NY 10016 USA
[3] RIKEN, INST PHYS & CHEM RES, TSUKUBA LIFE SCI CTR, GENE TECHNOL & SAFETY LAB, TSUKUBA, IBARAKI 305, JAPAN
[4] RAYMOND & BEVERLY SACKLER FDN LAB, NEW YORK, NY 10016 USA
关键词
D O I
10.1002/jcp.1041630124
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The activation of latent transforming growth factor-beta (TGF-beta) by vascular endothelial cells (ECs) is regulated by cellular plasminogen activator (PA)/plasmin, transglutaminase (TGase), and latent TGF-beta levels. Because lipopolysaccharide (LPS) has been reported to reduce EC surface plasmin levels by increasing the production of the inhibitor of PA, PA inhibitor-1 (PAI-1), we have tested whether LPS might suppress latent TGF-beta activation in ECs using two different systems, namely, bovine aortic ECs (BAECs) cocultured with smooth muscle cells (SMCs) and BAECs treated with retinol. BAECs were either cocultured with SMCs after treatment with 15 ng/ml LPS or were treated with 2 mu M retinol and/or 10 ng/ml LPS, and the expression of PA, surface plasmin, TGase, and the amounts of active and latent TGF-beta secreted into the culture medium were measured. The downregulation of surface PA/plasmin levels with LPS was accompanied by a profound decline of both TGase and latent TGF-beta expression as well as the suppression of surface activation of latent TGF-beta. The effect was dependent on the concentration of LPS and on treatment time. The formation of TGF-beta did not occur in cells maintained in LPS-contaminated culture medium. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:210 / 219
页数:10
相关论文
共 51 条
[1]   AN ACTIVATED FORM OF TRANSFORMING GROWTH FACTOR-BETA IS PRODUCED BY COCULTURES OF ENDOTHELIAL-CELLS AND PERICYTES [J].
ANTONELLIORLIDGE, A ;
SAUNDERS, KB ;
SMITH, SR ;
DAMORE, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4544-4548
[2]   LIPOPOLYSACCHARIDE MODULATES THE EXPRESSION OF ALPHA-1 PROTEINASE-INHIBITOR AND OTHER SERINE PROTEINASE-INHIBITORS IN HUMAN-MONOCYTES AND MACROPHAGES [J].
BARBEYMOREL, C ;
PIERCE, JA ;
CAMPBELL, EJ ;
PERLMUTTER, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :1041-1054
[3]   THE CELL BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BARNARD, JA ;
LYONS, RM ;
MOSES, HL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :79-87
[4]  
BEUTLER B, 1990, HDB EXPT PHARM 2, V95, P39
[5]  
BRANDES ME, 1991, J BIOL CHEM, V266, P19697
[6]  
Chen T Y, 1992, Curr Top Microbiol Immunol, V181, P169
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   CULTURED HUMAN-ENDOTHELIAL CELLS GENERATE TISSUE FACTOR IN RESPONSE TO ENDOTOXIN [J].
COLUCCI, M ;
BALCONI, G ;
LORENZET, R ;
PIETRA, A ;
LOCATI, D ;
DONATI, MB ;
SEMERARO, N .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (06) :1893-1896
[9]   CELLULAR ACTIVATION OF LATENT TRANSFORMING GROWTH-FACTOR-BETA REQUIRES BINDING TO THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH-FACTOR TYPE-II RECEPTOR [J].
DENNIS, PA ;
RIFKIN, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :580-584
[10]  
DERYNCK R, 1986, J BIOL CHEM, V261, P4377